Proposed Data Collection; Comment Request; National Survey of Primary Care Physicians' Recommendations and Practice for Breast, Cervical, Colorectal, and Lung Cancer Screening, 3309 [06-512]
Download as PDF
<![CDATA[
3309
Federal Register / Vol. 71, No. 13 / Friday, January 20, 2006 / Notices
Dated: January 12, 2006.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E6–628 Filed 1–19–06; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Data Collection; Comment
Request; National Survey of Primary
Care Physicians’ Recommendations
and Practice for Breast, Cervical,
Colorectal, and Lung Cancer
Screening
SUMMARY: In compliance with the
provisions of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comments on
proposed data collection projects, the
National Institutes of Health (NIH),
National Cancer Institute (NCI) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection: Title: National
Survey of Primary Care Physicians’
Recommendations and Practice for
Breast, Cervical, Colorectal, and Lung
Cancer Screening. Type of Information
Collection Request: New. Need and Use
of Information Collection: This study
will obtain current, national data on
primary care physicians’ knowledge,
attitudes, recommendations, and
practices related to screening for breast,
cervical, colorectal, and lung cancer.
There have been substantial changes in
Estimated
number of
respondents
Questionnaire
guidelines and/or technologies for these
types of cancer screening in recent
years. The data collected in this study
will support and further NCI work in
monitoring and evaluating providers’
cancer control knowledge, attitudes, and
practices and their impact on
population health, as well as enable
monitoring of progress toward major
cancer control goals. Two
questionnaires, one covering breast and
cervical cancer screening and the other
colorectal and lung cancer screening,
will be administered by mail or
telephone to a randomly-selected
national sample of primary care
physicians. Frequency of Response: One
Time. Affected Public: Medical
practices, clinics, or other health care
organizations. Type of Respondents:
Primary Care Physicians. Burden
estimates are as follows:
Estimated
number of
responses per
respondent
Average
burden hours
per response
Estimated total
annual burden
hours
1250
1250
1
1
0.333
0.333
416.25
416.25
Total ..........................................................................................................
wwhite on PROD1PC65 with NOTICES
Breast and cervical cancer screening .............................................................
Colorectal and lung cancer screening .............................................................
........................
........................
........................
832.5
There are no Capital Costs to report.
There are no Operating or Maintenance
Costs to report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(a) Whether the proposed collection of
information is necessary for the
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
FOR FURTHER INFORMATION CONTACT:
Send comments to Carrie N. Klabunde,
Ph.D., Epidemiologist, Division of
Cancer Control and Population
Sciences, National Cancer Institute,
Executive Plaza North 4005, 6130
Executive Boulevard, Bethesda,
Maryland 20892–7344 or call non-tollfree (301) 402–3362 or E-mail:
klabundc@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
VerDate Aug<31>2005
16:16 Jan 19, 2006
Jkt 208001
received within 60 days of the date of
this publication.
Dated: January 11, 2006.
Rachelle Ragland-Greene,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 06–512 Filed 1–19–06; 8:45 am]
BILLING CODE 4101–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health/National
Institute of Environmental Health
Sciences
Laboratory of Pulmonary
Pathobiology; Submission for OMB
Review; Comment Request; Use of InHome Test Kits in Dust Mite Allergen
Reduction
SUMMARY: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institute of Environmental Health
Sciences (NIEHS), the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request to review and approve
the information collection listed below.
This proposed information collection
was previously published in the Federal
Register on October 21, 2004, pages
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
61853–61854, and allowed 60 days for
public comment. No public comments
were received although one person sent
an e-mail expressing interest in the
study and asking if she could
participate. She was told this was a pilot
study to be carried out in a specific
location in North Carolina. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Institutes of Health may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Proposed Collection: Title: Use of Inhome Test Kits in Dust Mite Allergen
Reduction. Type of Information
Collection Request: New. Need and Use
of Information Collection: This request
for OMB review and approval of the
information collection is required by
regulation 42 CFR part 65(a)(6).
Asthmatics and others with dust mite
allergies often implement strategies to
avoid dust mite exposure, but have little
objective evidence that their
interventions are successful in reducing
dust mite populations. Recently
developed in-home test kits have
introduced the capability to monitor the
effectiveness of allergen reduction
strategies by providing an affordable,
E:\FR\FM\20JAN1.SGM
20JAN1
]]>Agencies
[Federal Register Volume 71, Number 13 (Friday, January 20, 2006)]
[Notices]
[Page 3309]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-512]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Data Collection; Comment Request; National Survey of
Primary Care Physicians' Recommendations and Practice for Breast,
Cervical, Colorectal, and Lung Cancer Screening
SUMMARY: In compliance with the provisions of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public
comments on proposed data collection projects, the National Institutes
of Health (NIH), National Cancer Institute (NCI) will publish periodic
summaries of proposed projects to be submitted to the Office of
Management and Budget (OMB) for review and approval.
Proposed Collection: Title: National Survey of Primary Care
Physicians' Recommendations and Practice for Breast, Cervical,
Colorectal, and Lung Cancer Screening. Type of Information Collection
Request: New. Need and Use of Information Collection: This study will
obtain current, national data on primary care physicians' knowledge,
attitudes, recommendations, and practices related to screening for
breast, cervical, colorectal, and lung cancer. There have been
substantial changes in guidelines and/or technologies for these types
of cancer screening in recent years. The data collected in this study
will support and further NCI work in monitoring and evaluating
providers' cancer control knowledge, attitudes, and practices and their
impact on population health, as well as enable monitoring of progress
toward major cancer control goals. Two questionnaires, one covering
breast and cervical cancer screening and the other colorectal and lung
cancer screening, will be administered by mail or telephone to a
randomly-selected national sample of primary care physicians. Frequency
of Response: One Time. Affected Public: Medical practices, clinics, or
other health care organizations. Type of Respondents: Primary Care
Physicians. Burden estimates are as follows:
----------------------------------------------------------------------------------------------------------------
Estimated
Estimated number of Average Estimated
Questionnaire number of responses per burden hours total annual
respondents respondent per response burden hours
----------------------------------------------------------------------------------------------------------------
Breast and cervical cancer screening............ 1250 1 0.333 416.25
Colorectal and lung cancer screening............ 1250 1 0.333 416.25
-----------------
Total....................................... .............. .............. .............. 832.5
----------------------------------------------------------------------------------------------------------------
There are no Capital Costs to report. There are no Operating or
Maintenance Costs to report.
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (a) Whether the proposed collection of information is
necessary for the performance of the functions of the agency, including
whether the information shall have practical utility; (b) the accuracy
of the agency's estimate of the burden of the proposed collection of
information; (c) ways to enhance the quality, utility, and clarity of
the information to be collected; and (d) ways to minimize the burden of
the collection of information on respondents, including through the use
of automated collection techniques or other forms of information
technology.
FOR FURTHER INFORMATION CONTACT: Send comments to Carrie N. Klabunde,
Ph.D., Epidemiologist, Division of Cancer Control and Population
Sciences, National Cancer Institute, Executive Plaza North 4005, 6130
Executive Boulevard, Bethesda, Maryland 20892-7344 or call non-toll-
free (301) 402-3362 or E-mail: klabundc@mail.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Dated: January 11, 2006.
Rachelle Ragland-Greene,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 06-512 Filed 1-19-06; 8:45 am]
BILLING CODE 4101-01-P
